Diana Bonet-Badenes
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial.
Journal: The European respiratory journal
Published: March 11, 2024
Overnight desaturation in interstitial lung diseases: links to pulmonary vasculopathy and mortality.
Overnight desaturation in interstitial lung diseases: links to pulmonary vasculopathy and mortality.
Journal: ERJ open research
Published: October 04, 2023
Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2.
Journal: Respiration; international review of thoracic diseases
Published: September 08, 2023
Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19.
Journal: International journal of chronic obstructive pulmonary disease
Published: July 02, 2023
Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?
Journal: Frontiers in medicine
Published: June 07, 2023
Treatment of COVID-19 during the Acute Phase in Hospitalized Patients Decreases Post-Acute Sequelae of COVID-19.
Journal: Journal of clinical medicine
Published: April 22, 2023
Benefits of a Homecare Integral Patient Support Program in Idiopathic Pulmonary Fibrosis.
Journal: Archivos de bronconeumologia
Published: February 03, 2023
Predictors and changes of physical activity in idiopathic pulmonary fibrosis.
Journal: BMC pulmonary medicine
Published: May 03, 2022
Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity.
Journal: Archivos de bronconeumologia
Published: December 14, 2020
Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggers.
Journal: Respirology (Carlton, Vic.)
Published: February 25, 2020
Last Updated: 09/26/2026